The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
New findings pave way to potentially improved assessment of measurable residual disease in AML patients
New service reduces project time from months to weeks for biopharma customers
Hear from a microbiology expert at Yale School of Public Health about a simplified PCR test for COVID-19
The research describes a new family of enzymes for pharmaceutical production
The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted
The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes
Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min
Dr. Boye Schnack Nielsen shares tips for running successful in situ hybridization assays as he provides insights on how RNA detection methods have evolved over time
The seamless integration of AI into digital pathology workflows aims to improve quality and efficiency of cancer diagnosis
The antigen test is used to detect the nucleocapsid protein antigen in SARS-CoV-2
m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020
Explore topics from micro- and nanoscale LC-MS analysis to NGS sample quality control, EEM and A-TEEM spectroscopy, and oligonucleotide analysis
Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing
The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction
